首页> 美国政府科技报告 >Agonists of A2A Adenosine Receptors for Treatment of Diabetic Nephropathy.
【24h】

Agonists of A2A Adenosine Receptors for Treatment of Diabetic Nephropathy.

机译:a2a腺苷受体激动剂治疗糖尿病肾病。

获取原文

摘要

The present invention provides a therapeutic method for treating diabetic kidney disease, e.g., diabetic nephropathy that includes the administration of an effective amount of an A(sub 2A) adenosine receptor agonist. Optionally, the method includes administration of a type IV PDE inhibitor.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号